𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Myeloprotection of recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) given before MVAC regimen in patients with transitional cell carcinoma

✍ Scribed by Linassier, C.; Hetroy, J.; Boutin, J.M.; Laplaige, P.; Haillot, O.; Lucas, V.; Peyrat, L.; Azema, C.; Lanson, Y.; Colombat, P.

Book ID
122596884
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
149 KB
Volume
35
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Eosinophilia resulting from administrati
Eosinophilia resulting from administration of recombinant granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in a patient with T-Ξ³ lymphoproliferative disease
✍ R. Gonzales-Chambers; Dr. C. Rosenfeld; A. Winkelstein; L. Dameshek πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 217 KB πŸ‘ 2 views

A therapeutic trial of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) was attempted in a patient with neutropenia and frequent infections secondary to T-y lymphoproliferative disease (T-y LPD). During the 14 days of subcutaneous rhGM-CSF (500 kg/m2/day), the absolute e